Dugic, A.; Verdejo Gil, C.; Mellenthin, C.; Vujasinovic, M.; Löhr, J.-M.; Mühldorfer, S.
The Clinical Utility of Soluble Serum Biomarkers in Autoimmune Pancreatitis: A Systematic Review. Biomedicines 2022, 10, 1511.
https://doi.org/10.3390/biomedicines10071511
AMA Style
Dugic A, Verdejo Gil C, Mellenthin C, Vujasinovic M, Löhr J-M, Mühldorfer S.
The Clinical Utility of Soluble Serum Biomarkers in Autoimmune Pancreatitis: A Systematic Review. Biomedicines. 2022; 10(7):1511.
https://doi.org/10.3390/biomedicines10071511
Chicago/Turabian Style
Dugic, Ana, Cristina Verdejo Gil, Claudia Mellenthin, Miroslav Vujasinovic, J.-Matthias Löhr, and Steffen Mühldorfer.
2022. "The Clinical Utility of Soluble Serum Biomarkers in Autoimmune Pancreatitis: A Systematic Review" Biomedicines 10, no. 7: 1511.
https://doi.org/10.3390/biomedicines10071511
APA Style
Dugic, A., Verdejo Gil, C., Mellenthin, C., Vujasinovic, M., Löhr, J.-M., & Mühldorfer, S.
(2022). The Clinical Utility of Soluble Serum Biomarkers in Autoimmune Pancreatitis: A Systematic Review. Biomedicines, 10(7), 1511.
https://doi.org/10.3390/biomedicines10071511